| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/12/2001 | CA2071408C Tablet for slow release of indapamine after oral administration |
| 06/07/2001 | WO2001040446A1 Pour-on formulations |
| 06/07/2001 | WO2001040370A2 Ionically crosslinked hydrogels with adjustable gelation time |
| 06/07/2001 | WO2001040240A2 Mono- and disaccharide derivatives |
| 06/07/2001 | WO2001039815A2 Targeted drug delivery with a cd44 receptor ligand |
| 06/07/2001 | WO2001039812A1 A bioabsorbable drug delivery system |
| 06/07/2001 | WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | WO2001039794A1 Insulin-containing medicament for peroral application and method for the production thereof |
| 06/07/2001 | WO2001039789A1 Carbon dioxide enhancement of inhalation therapy |
| 06/07/2001 | WO2001039788A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 06/07/2001 | WO2001039774A1 Topical administration of ketotifen |
| 06/07/2001 | WO2001039772A1 Pharmaceutical formulations containing zolmitriptan |
| 06/07/2001 | WO2001039756A1 Patch therapeutic agent delivery device having texturized backing |
| 06/07/2001 | WO2001039754A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 06/07/2001 | WO2001039753A1 Transdermal therapeutic systems with improved stability and a method for the production thereof |
| 06/07/2001 | WO2001039750A1 Effervescent histamine h2 antagonist composition |
| 06/07/2001 | WO2001039745A2 Aerosol composition comprising formoterol |
| 06/07/2001 | WO2001039744A2 Radiation sensitive liposomes |
| 06/07/2001 | WO2001039742A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 06/07/2001 | WO2001039741A2 Mitomycin c solution |
| 06/07/2001 | WO2001039725A2 Drug preparations |
| 06/07/2001 | WO2001039724A2 Phosphonate compounds |
| 06/07/2001 | WO2001039608A1 Addition of tetracyclines to animal foodstuffs |
| 06/07/2001 | WO2001039582A1 Use of a buffer to prevent candida albicans infections on the skin |
| 06/07/2001 | WO2001013780A3 Apparatus and method for anesthetizing the cervical region of a female |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | US20010003126 Composition of first synthetic polymer having nucleophilic groups and second polymer having electrophilic groups capable of reacting to form covalent bonds with the first polymer; formation of a synthetic lenticule |
| 06/07/2001 | US20010003003 Preservative for emulsion and emulsion containing same |
| 06/07/2001 | US20010003001 Compounds and compositions for delivering active agents |
| 06/07/2001 | US20010002998 Over-coated chewing gum formulations including tableted center |
| 06/07/2001 | DE19957916A1 Neue Proteinkonjugate und Verfahren zu deren Herstellung New protein conjugates and methods for their preparation |
| 06/07/2001 | DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 06/07/2001 | DE19916211C2 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations |
| 06/07/2001 | DE19916210C2 Kosmetische Zubereitungen Cosmetic preparations |
| 06/07/2001 | CA2747954A1 Phosphonate compounds |
| 06/07/2001 | CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | CA2393233A1 Carbon dioxide enhancement of inhalation therapy |
| 06/07/2001 | CA2392795A1 Insulin-containing medicament for peroral application and method for the production thereof |
| 06/07/2001 | CA2392402A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 06/07/2001 | CA2392102A1 Use of a buffer to prevent candida albicans infections on the skin |
| 06/07/2001 | CA2390841A1 Drug preparations |
| 06/07/2001 | CA2390838A1 Patch therapeutic agent delivery device having texturized backing |
| 06/07/2001 | CA2388026A1 Targeted drug delivery with a cd44 receptor ligand |
| 06/07/2001 | CA2327369A1 Diluent and disintegrating composition, process for obtaining it and its use |
| 06/06/2001 | EP1104777A1 Gelatin and a process for producing the same |
| 06/06/2001 | EP1104767A1 Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups |
| 06/06/2001 | EP1104677A2 Proteinconjugates and their preparation |
| 06/06/2001 | EP1104482A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 06/06/2001 | EP1104408A2 Drug targeting |
| 06/06/2001 | EP1104313A2 Methods, instruments and materials for chondrocyte cell transplantation |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | EP1104308A1 Antibodies for use in targeted and temporary treatment of humans and animals |
| 06/06/2001 | EP1104304A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 06/06/2001 | EP1104296A1 Bioimplant formulation |
| 06/06/2001 | EP1104291A1 Pellets having a core coated with an antifungal and a polymer |
| 06/06/2001 | EP1104290A1 Microemulsions as solid dosage forms for oral administration |
| 06/06/2001 | EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists |
| 06/06/2001 | EP1104288A1 Orally disintegrable tablet forming a viscous slurry |
| 06/06/2001 | EP1104287A2 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof |
| 06/06/2001 | EP1104280A2 Topical delivery systems for active agents |
| 06/06/2001 | EP1104236A1 Transdermally delivered aspirin |
| 06/06/2001 | EP1005324A4 Compositions for delivery of biological agents and methods for the preparation thereof |
| 06/06/2001 | CN1298311A A drug composition containing sodium Pravastatin |
| 06/06/2001 | CN1298310A Stable mitoxantron solutions |
| 06/06/2001 | CN1298306A Treatment of i (C. Difficile) toxin B associated conditions |
| 06/06/2001 | CN1298303A Stable compositions comprising levosimendan and alginic acid |
| 06/06/2001 | CN1298300A Fire-resistant non-explosive solid mixtures containing nitroglycerine and water-free lactose |
| 06/06/2001 | CN1298297A Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 06/06/2001 | CN1298296A Erythropoietin Liposomal dispersion |
| 06/06/2001 | CN1298295A Method and compositions for stabilizing acetylcholine compositions |
| 06/06/2001 | CN1298294A Nicotine inhaler |
| 06/06/2001 | CN1066624C Dry mix formulation for bisphosphonic acids |
| 06/05/2001 | US6242499 Polyglycerol partial esters of fatty acids and polyfunctional carboxylic acids, their preparation and use |
| 06/05/2001 | US6242496 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| 06/05/2001 | US6242482 Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure |
| 06/05/2001 | US6242430 Cyclodextrin-based rotaxane dyes, labeling agent using the dye, and a method for labeling |
| 06/05/2001 | US6242423 The pharmaceutical composition can be used for injection or for percutaneous or ocular application. |
| 06/05/2001 | US6242195 Methods for determining binding of an analyte to a receptor |
| 06/05/2001 | US6242008 Spherical pharmaceutical granules comprising microcrystalline cellulose and a process for their production |
| 06/05/2001 | US6242004 Bioadhesive tablets |
| 06/05/2001 | US6242003 Organic compounds |
| 06/05/2001 | US6242002 Rapidly disintegrating oral dosage form of alkali-sensitive material, effervescent base of alkaline earth metal carbonate, organic edible acid and alkali metal salt of citric acid, auxiliary ingredients |
| 06/05/2001 | US6241999 Substituting first amphipathic lipid with one having a similiar structure but more c atoms |
| 06/05/2001 | US6241988 Stable extract of hypericum perforatum L., a method for producing the same, and corresponding pharmaceutical preparations |
| 06/05/2001 | US6241969 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| 06/05/2001 | US6241961 Administering to bone marrow of patient a dose of a monoclonal antibody or antibody fragment stably coupled to a cadmium-66 radioisotope; side effect reduction |
| 06/05/2001 | US6241812 Acid-stable and cationic-compatible cellulose compositions and methods of preparation |
| 06/05/2001 | CA2198852C Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides |
| 06/05/2001 | CA2051621C Oil-in-water type emulsified composition comprising non-steroidal antiphlogistic and analgesic drug |
| 06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
| 06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
| 06/01/2001 | CA2327140A1 Novel protein conjugates and process for the preparation thereof |
| 05/31/2001 | WO2001038552A2 Excipient system that contains coating substances with enzymatically removable side-groups |
| 05/31/2001 | WO2001038547A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 05/31/2001 | WO2001038496A1 A human normal counterpart of cd4+ cd56+ cutaneous neoplasm |
| 05/31/2001 | WO2001038335A1 Phosphorus-containing dendrimers as transfection agents |
| 05/31/2001 | WO2001038318A1 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/31/2001 | WO2001037896A2 Methods and compositions for administration of therapeutic reagents |
| 05/31/2001 | WO2001037890A1 A propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 05/31/2001 | WO2001037883A1 Complexes of alkylphosphonic acids |